• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Suzuki Takuma  鈴木 拓真

ORCIDConnect your ORCID iD *help
Researcher Number 90867938
Affiliation (Current) 2025: 株式会社Good Hero Therapeutics(研究開発部), 研究開発部, 研究員
Affiliation (based on the past Project Information) *help 2025: 株式会社Good Hero Therapeutics(研究開発部), 研究開発部, 研究員
2023: 東京薬科大学, その他部局等, アルバイト職員
2022: 東京大学, 医科学研究所, 特任研究員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords
Principal Investigator
腫瘍溶解性HSV / ヘルペスウイルス / oHSV / 腫瘍溶解性ウイルス療法 / ネクロプトーシス / 多核巨細胞 / 単純ヘルペスウイルス / 遺伝子治療 / 細胞死 / がん
  • Research Projects

    (2 results)
  • Research Products

    (6 results)
  •  膜融合型腫瘍溶解性ヘルペスウイルスの腫瘍送達効率の増強Principal Investigator

    • Principal Investigator
      鈴木 拓真
    • Project Period (FY)
      2025 – 2026
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Good Hero Therapeutics Inc. Research and Development Dept.
  •  Identification of cell death mechanism involved in multinucleated giant cell death induced by syncytial oncolytic HSVPrincipal Investigator

    • Principal Investigator
      Suzuki Takuma
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Tokyo University of Pharmacy and Life Science
      The University of Tokyo

All 2024 2023

All Journal Article Presentation

  • [Journal Article] Induction of necroptosis in multinucleated giant cells induced by conditionally replicating syncytial oHSV in co-cultures of cancer cells and non-cancerous cells2024

    • Author(s)
      Suzuki Takuma、Uchida Hiroaki
    • Journal Title

      Molecular Therapy: Oncology

      Volume: 32 Issue: 2 Pages: 200803-200803

    • DOI

      10.1016/j.omton.2024.200803

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K15553
  • [Presentation] 多核巨細胞形成型腫瘍溶解性HSVの感染拡大はがん細胞と非がん細胞の融合により誘導される細胞死によって抑制される2023

    • Author(s)
      鈴木拓真、内田宏昭
    • Organizer
      第1回日本ウイルス療法学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K15553
  • [Presentation] 受容体標的化腫瘍溶解性単純ヘルペスウイルス(RR-oHSV)へのsyn変異の導入による抗腫瘍効果の増強2023

    • Author(s)
      鈴木拓真、田原秀晃、内田宏昭
    • Organizer
      第46回日本分子生物学会年会
    • Data Source
      KAKENHI-PROJECT-22K15553
  • [Presentation] 受容体標的化腫瘍溶解性HSV(RR-oHSV)へのsyn変異の導入による抗腫瘍効果の増強2023

    • Author(s)
      鈴木拓真、田原秀晃、内田宏昭
    • Organizer
      第1回日本ウイルス療法学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K15553
  • [Presentation] Augmentation of anti-tumor effects of receptor-retargeted oncolytic HSV (RR-oHSV) through introduction of syn mutations2023

    • Author(s)
      Takuma Suzuki, Hideaki Tahara, Hiroaki Uchida
    • Organizer
      第29回日本遺伝子細胞治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K15553
  • [Presentation] Development of IL13RA2-retargeted syncytial oncolytic herpes simplex virus (IL13RA2-specific RRsyn-oHSV)2023

    • Author(s)
      Takuma Suzuki, Hideaki Tahara, Hiroaki Uchida
    • Organizer
      第96回日本生化学会大会
    • Data Source
      KAKENHI-PROJECT-22K15553

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi